Trial Profile
A randomized, double-blind, placebo-controlled add-on trial of quetiapine in patients with bipolar disorder and cocaine dependence.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Cocaine-related disorders
- Focus Therapeutic Use
- 17 Aug 2012 Actual end date (1 Dec 2007) added as reported by ClincalTrials.gov.
- 02 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned end date (Dec 2007) added as reported by ClinicalTrials.gov.